The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.

AusPAR: Brexpiprazole

Australian Public Assessment Report

AusPAR

AusPAR: Brexpiprazole [PDF, 1.41 MB]

AusPAR: Brexpiprazole [Word, 3.66 MB]

Attachment: Product Information: Brexpiprazole [PDF, 355.07 KB]

Attachment: Product Information: Brexpiprazole [Word, 363.77 KB]

Attachment: Extract from Clinical Evaluation: Brexpiprazole [PDF, 1.58 MB]

Attachment: Extract from Clinical Evaluation: Brexpiprazole [Word, 2.22 MB]

Device/Product Name

Rexulti

Active ingredients

Brexpiprazole

AusPAR Date

24 September 2018

Published

15 November 2018

Submission Number

PM-2016-009095-1-1

Submission Type

New chemical entity

Decision

Approved